Liminatus Pharma, Inc. Class A Common Stock (LIMN) is a publicly traded Healthcare sector company. As of September 8, 2026, LIMN trades at $3.68 with a market cap of $4.98M and a P/E ratio of -8.63. LIMN moved +0.00% today. Year to date, LIMN is -87.84%; over the trailing twelve months it is -97.22%. Its 52-week range spans $3.42 to $1,683.00. Rallies surfaces LIMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks LIMN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.68 |
| Market Cap | $4.98M |
| P/E Ratio | -8.63 |
| EPS | $-0.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,683.00 |
| 52-Week Low | $3.42 |
| Volume | 17.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.21M |
| Gross Margin | 0.00% |
LIMN analyst coverage data. Average price target: $0.00.